Human Phospho-MAPK Array Kit from R&D Systems
...lone d1-174 GenBank Accession Number : NM_006225 ...sion protein corresponding to full length rat PLC ...15M NaCl, 0.05% sodium azide before the addition o...luated by immunoblot on RIPA lysates from PC-12 ce...
Rat CXCL7 (NAP-2) ELISA development Kit, DuoSet Economy Pack from R&D Systems
Rat Fas, Unconjugated from R&D Systems
Biology Products:(Date:11/23/2009)...CT Current research suggests that a common oral b...elated report by Nichols et al, "Unique Lipids fro...f TLR2 Ligands Capable of Enhancing Autoimmunity,"...an Journal of Pathology . , Multiple sclerosis (... brain and spinal cord, affects nearly 1 in 700 pe...
(Date:11/23/2009)... - The only swine vaccine available for the H1N1 v...ted with the virus. The vaccination marks the firs...osed with the pandemic flu., Iowa State Universi...eloped the vaccine this summer and has been shippi...nsas and Illinois for several weeks., The latest...
(Date:11/23/2009)... November 16, 2009 -- A USDOE and USDA study concl...cropland, and cropland pasture could be converted ...rasses, such as switchgrass, from which biomass co...conomically viable production of a perennial grass...biomass are removed annually is expected to requir...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2Almost Half of Those Over 60 Die While Waiting for Kidney Transplant 49426 1Almost Half of Those Over 60 Die While Waiting for Kidney Transplant 49426 2Almost Half of Those Over 60 Die While Waiting for Kidney Transplant 49426 3MedQuist Adds Kevin Piltz as New Chief Information Officer 49424 1MedQuist Adds Kevin Piltz as New Chief Information Officer 49424 2ERT Officials Ring the NASDAQ Closing Bell 49422 1ERT Officials Ring the NASDAQ Closing Bell 49422 2ERT Officials Ring the NASDAQ Closing Bell 49422 3(Date:11/24/2009)... Shire plc (LSE: SHP,NA...ical company, today,announced that it has submitte...lucerase alfa, the company,s enzyme replacement th...aucher disease. This is the third marketing,applic...ed, with previous,submissions in the United States...
(Date:11/24/2009)...Nov. 24 Genomic Health, ...cott, Genomic Health,s Executive Chairman, will pr... Conference in New York City on Tuesday, December ...e and subsequently archived webcast of the present...omic Health,s website at http://investor.genomich...
(Date:11/24/2009)...nnects Customers with Partners Validated to Proces...roducts , Ottawa, ON (PRW...provider of products for biological sample collect...d its new global partner program. The program offe...ner community and is designed to help partners sca...
(Date:11/24/2009)...Newswire-FirstCall/ -- Cell Therapeutics, Inc. (CT...at the 21st Annual Piper Jaffray Health Care Confe...009, at the New York Palace Hotel. ,, CTI wil...tern Time in Holmes 1 (4th Floor). A live audio we...www.celltherapeutics.com , and it will also be ava...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3